New cancer clinical trial: A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities

Published on: January 25, 2018 at 12:00PM
Condition:   Advanced Solid Tumors With HER2 or HER3 Abnormalities
Intervention:   Drug: TAS0728
Sponsor:   Taiho Oncology, Inc.
Not yet recruiting
http://ift.tt/2DHxEXZ